Radical prostatectomy or radiotherapy in high-risk prostate cancer: A systematic review and metaanalysis

Clinical Genitourinary Cancer

Volumn 12, Issue 4, 2014, Pages 215-224

  Petrelli, Fausto ^a   Vavassori, Ivano ^a   Coinu, Andrea ^a   Borgonovo, Karen ^a   Sarti, Enrico ^a   Barni, Sandro ^a  

^a TREVIGLIO HOSPITAL   (Italy)

Author keywords

Cancer mortality; Overall survival; Prostate carcinoma; Radiation therapy; Surgery

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HIGH RISK PATIENT; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; COMPARATIVE STUDY; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTOR;

HUMANS; MALE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; RISK FACTORS;

EID: 84904733372     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.01.010     Document Type: Review

References (41)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
2. A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
3. I. Thompson, J.B. Thrasher, and G. Aus et al. Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
4. S.A. Boorjian, R.J. Karnes, and L.J. Rangel et al. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354 1360 discussion 1360-1
5. Sun M, Sammon JD, Becker A, et al. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int, Published online June 20, 2013; http://dx.doi.org/10.1111/bju.12321.
6. O. Yossepowitch, S.E. Eggener, and A.M. Serio et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy Eur Urol 53 2008 950 959
7. M.J. Zelefsky, Y. Yamada, and Z. Fuks et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes Int J Radiat Oncol Biol Phys 71 2008 1028 1033
8. K. Akakura, H. Suzuki, and T. Ichikawa et al. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months Jpn J Clin Oncol 36 2006 789 793
9. F. Abdollah, J. Schmitges, and M. Sun et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis Int J Urol 19 2012 836 844 author reply 844-5
10. D.F. Stroup, J.A. Berlin, and S.C. Morton et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
11. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
12. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 101 129
13. J.P. Higgins, S.G. Thompson, and J.J. Deeks et al. Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
14. M. Egger, D.G. Smith, and M. Schneider et al. Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
15. R.M. Hoffman, T. Koyama, and K.H. Fan et al. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer J Natl Cancer Inst 105 2013 711 718
16. S.A. Boorjian, R.J. Karnes, and R. Viterbo et al. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer Cancer 117 2011 2883 2891
17. A.A. Aizer, J.B. Yu, and J.W. Colberg et al. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma Radiother Oncol 93 2009 185 191
18. G. Arcangeli, L. Strigari, and S. Arcangeli et al. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer Int J Radiat Oncol Biol Phys 75 2009 975 982
19. I. Takizawa, N. Hara, and T. Nishiyama et al. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification Asian J Androl 11 2009 283 290
20. P.L. Nguyen, M.H. Chen, and W.J. Catalona et al. Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors Int J Radiat Oncol Biol Phys 73 2009 659 664
21. A. Tewari, G. Divine, and P. Chang et al. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy-a propensity scoring approach [published erratum appears in: J Urol 2007; 177:1958] J Urol 177 2007 911 915
22. H.K. Tsai, M.H. Chen, and D.G. McLeod et al. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer Cancer 107 2006 2597 2603
23. T. Saito, Y. Kitamura, and S. Komatsubara et al. Outcomes of locally advanced prostate cancer: a single institution study of 209 patients in Japan Asian J Androl 8 2006 555 561
24. A.V. D'Amico, J. Moul, and P.R. Carroll et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 21 2003 2163 2172
25. P.A. Kupelian, J.C. Buchsbaum, and M. Elshaikh et al. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above Cancer 95 2002 2302 2307
26. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate-specific antigen era Cancer 95 2002 281 286
27. M.J. Barry, P.C. Albertsen, and M.A. Bagshaw et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis Cancer 91 2001 2302 2314
28. S.H. Stokes Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation Int J Radiat Oncol Biol Phys 47 2000 129 136
29. J.P. Ciezki, S.A. Koyfman, and C.A. Reddy et al. Biochemical relapse-free survival in patients with high-risk prostate cancer treated with external beam radiotherapy, permanent seed implant monotherapy or radical prostatectomy Int J Radiat Oncol Biol Phys 72 2008 S295
30. T.J. Wilt, M.K. Brawer, and K.M. Jones et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
31. A. Briganti, M. Spahn, and S. Joniau et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis Eur Urol 63 2013 693 701
32. P. Sooriakumaran, R. Haendler, and T. Nyberg et al. Surgery versus radiotherapy in prostate cancer: analysis of mortality outcomes in 34,515 patients treated with up to 15 years follow-up (abstract) J Urol 189 suppl 4 2013 E135 E136
33. S. Ladjevardi, A. Berglund, and E. Varenhorst et al. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11-380 men with serum PSA level 20-100-ng/mL BJU Int 111 2013 381 388
34. M.D. Mason, W. Parulekar, and M.R. Sydes et al. Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110) (abstract) J Clin Oncol 30 2012 4509
35. K.G. Nepple, A.J. Stephenson, and D. Kallogjeri et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity Eur Urol 64 2013 372 378
36. M.R. Cooperberg, A.J. Vickers, J.M. Broering, and P.R. Carroll Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer [published erratum appears in: Cancer2011; 117:2825] Cancer 116 2010 5226 5234
37. M.J. Resnick, T. Koyama, and K.H. Fan et al. Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
38. W. Lilleby, A. Stensvold, and A.A. Dahl Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of life Prostate 73 2013 1038 1047
39. N. Ohri, A.P. Dicker, and T.N. Showalter Late toxicity rates following definitive radiotherapy for prostate cancer Can J Urol 19 2012 6373 6380
40. G.A. Viani, E.J. Stefano, and S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
41. T. Daly, B.E. Hickey, M. Lehman, D.P. Francis, and A.M. See Adjuvant radiotherapy following radical prostatectomy for prostate cancer Cochrane Database Syst Rev 2011 CD007234